RDR03871

CAS No. 286008-51-3

RDR03871( RDR-03871 | RDR 03871 | ZINC20458540 )

Catalog No. M27921 CAS No. 286008-51-3

RDR03871 is an MDM2 inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 264 Get Quote
5MG 403 Get Quote
10MG 592 Get Quote
25MG 888 Get Quote
50MG 1242 Get Quote
100MG 1701 Get Quote
500MG 3402 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    RDR03871
  • Note
    Research use only, not for human use.
  • Brief Description
    RDR03871 is an MDM2 inhibitor.
  • Description
    RDR03871 is an MDM2 inhibitor.(In Vitro):RDR03871 dissociated the MDM2/p53 with IC50 of 12.9nM in quantitative sandwich immune-enzymatic assays.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    RDR-03871 | RDR 03871 | ZINC20458540
  • Pathway
    Apoptosis
  • Target
    MDM2-p53
  • Recptor
    Nucleoside Antimetabolite/Analog
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    286008-51-3
  • Formula Weight
    408.81
  • Molecular Formula
    C18H16ClF3N6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1nc(nc(NCCNc2cccc(n2)C(F)(F)F)c1Cl)-c1ccccn1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wipapat Kladwang, et al. Anomalous Reverse Transcription through Chemical Modifications in Polyadenosine Stretches. Biochemistry. 2020 Jun 16;59(23):2154-2170.
molnova catalog
related products
  • MI 219

    MI 219 is a potent, specific MDM2-p53 inhibitor with Ki of 5 nM, >10,000-fold selective for MDM2 over MDMX.

  • SM13

    SM13 is a novel small molecule that blocks p53-MDM2 interaction and induces apoptosis both in vitro and in vivo.

  • AQ-101

    AQ-101 is a novel small-molecule anthraquinone analog that induces MDM2 protein degradation (Kd=0.37 uM) through a self-ubiquitination and proteasome-mediated mechanism.